# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
101 | 500 Seo DJ, Patrick CJ, Kennealy PJAGGRESSION AND VIOLENT BEHAVIOR. 2008 OCT; 13 (5): 383-395
| 1 | 17 | 2 | 149
|
102 | 654 Kalivas PWNATURE REVIEWS NEUROSCIENCE. 2009 AUG; 10 (8): 561-572
| 11 | 78 | 19 | 148
|
103 | 413 Kalivas PW, O'Brien CNEUROPSYCHOPHARMACOLOGY. 2008 JAN; 33 (1): 166-180
| 25 | 120 | 13 | 147
|
104 | 394 Nader MA, Czoty PWILAR JOURNAL. 2008; 49 (1): 89-102
| 1 | 10 | 2 | 146
|
105 | 582 Moll J, Schulkin JNEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2009 MAR; 33 (3): 456-465
| 0 | 10 | 1 | 146
|
106 | 617 Vilpoux C, Warnault V, Pierrefiche O, Daoust M, Naassila MALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 2009 JUN; 33 (6): 945-969
| 0 | 8 | 4 | 146
|
107 | 454 Karila L, Gorelick D, Weinstein A, Noble F, Benyamina A, et al.INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2008 MAY; 11 (3): 425-438
| 1 | 42 | 6 | 144
|
108 | 715 Ray LA, Hutchison KE, Tartter MCURRENT PHARMACEUTICAL DESIGN. 2010; 16 (19): 2149-2158
| 0 | 2 | 4 | 144
|
109 | 559 Naqvi NH, Bechara ATRENDS IN NEUROSCIENCES. 2009 JAN; 32 (1): 56-67
| 16 | 53 | 10 | 143
|
110 | 854 Piray P, Keramati MM, Dezfouli A, Lucas C, Mokri ANEURAL COMPUTATION. 2010 SEP; 22 (9): 2334-2368
| 0 | 0 | 15 | 143
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
111 | 4 Everitt BJ, Wolf MEJOURNAL OF NEUROSCIENCE. 2002 MAY 1; 22 (9): 3312-3320
| 31 | 367 | 1 | 142
|
112 | 373 Yucel M, Lubman DI, Solowij N, Brewer WJAUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. 2007 DEC; 41 (12): 957-968
| 4 | 17 | 11 | 142
|
113 | 947 Kenny PJPHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR. 2011 FEB; 97 (4): 700-707
| 0 | 1 | 4 | 142
|
114 | 51 Dawes MA, Johnson BAALCOHOL AND ALCOHOLISM. 2004 MAY-JUN; 39 (3): 166-177
| 0 | 4 | 1 | 141
|
115 | 392 Iacono WG, Malone SM, McGue MANNUAL REVIEW OF CLINICAL PSYCHOLOGY. 2008; 4: 325-348
| 4 | 32 | 5 | 141
|
116 | 124 Kamarajan C, Porjesz B, Jones KA, Chorlian DB, Padmanabhapillai A, et al.CLINICAL NEUROPHYSIOLOGY. 2005 MAY; 116 (5): 1049-1061
| 2 | 23 | 1 | 140
|
117 | 395 Gonzalez R, Cherner MINTERNATIONAL REVIEW OF PSYCHIATRY. 2008; 20 (1): 49-60
| 2 | 5 | 3 | 140
|
118 | 546 Dalley JW, Fryer TD, Aigbirhio FI, Brichard L, Richards HK, et al.NEUROPHARMACOLOGY. 2009; 56: 9-17
| 0 | 3 | 9 | 140
|
119 | 140 Posner J, Russell JA, Peterson BSDEVELOPMENT AND PSYCHOPATHOLOGY. 2005 SUM; 17 (3): 715-734
| 0 | 60 | 1 | 139
|
120 | 470 Tovino SANEUROETHICS. 2008 JUL; 1 (2): 101-117
| 0 | 3 | 9 | 139
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
121 | 807 Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, et al.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2010 JUN; 69 (6): 578-592
| 0 | 9 | 6 | 139
|
122 | 808 Segarra AC, Agosto-Rivera JL, Febo M, Lugo-Escobar N, Menendez-Delmestre R, et al.HORMONES AND BEHAVIOR. 2010 JUN; 58 (1): 33-43
| 0 | 3 | 4 | 139
|
123 | 64 Esch T, Stefano GBNEUROENDOCRINOLOGY LETTERS. 2004 AUG; 25 (4): 235-251
| 4 | 57 | 1 | 138
|
124 | 914 Munoz MA, Sanjuan R, Fernandez-Santaella MC, Vila J, Montoya PADICCIONES. 2011; 23 (2): 111-123
| 0 | 0 | 7 | 138
|
125 | 1030 Hogarth LPSYCHOPHARMACOLOGY. 2011 JUN; 215 (3): 567-580
| 0 | 0 | 12 | 138
|
126 | 858 Martin-Soelch CZEITSCHRIFT FUR NEUROPSYCHOLOGIE. 2010 SEP; 21 (3): 153-166
| 0 | 3 | 9 | 137
|
127 | 134 Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare LNEUROPSYCHOLOGY REVIEW. 2005 JUN; 15 (2): 73-95
| 0 | 71 | 1 | 135
|
128 | 343 Matsumoto I, Alexander-Kaufman K, Iwazaki T, Kashem MA, Matsuda-Matsumoto HEXPERT REVIEW OF PROTEOMICS. 2007 AUG; 4 (4): 539-552
| 1 | 16 | 4 | 134
|
129 | 249 Petrakis ILJOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2006 DEC; 26: S3-S12
| 0 | 6 | 2 | 133
|
130 | 719 Sofuoglu MADDICTION. 2010 JAN; 105 (1): 38-48
| 5 | 14 | 18 | 133
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
131 | 856 Fecteau S, Fregni F, Boggio PS, Camprodon JA, Pascual-Leone ASUBSTANCE USE & MISUSE. 2010 SEP; 45 (11): 1766-1786
| 0 | 0 | 15 | 133
|
132 | 886 Van den Oever MC, Spijker S, Smit AB, De Vries TJNEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2010 NOV; 35 (2): 276-284
| 0 | 1 | 25 | 133
|
133 | 180 Verdejo-Garcia A, Perez-Garcia M, Bechara ACURRENT NEUROPHARMACOLOGY. 2006 JAN; 4 (1): 17-31
| 9 | 14 | 8 | 131
|
134 | 628 Dalley JW, Everitt BJSEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 2009 JUN; 20 (4): 403-410
| 5 | 16 | 13 | 131
|
135 | 708 Piechatzek M, Indlekofer F, Daamen M, Glasmacher C, Lieb R, et al.HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2009 DEC; 24 (8): 650-665
| 1 | 2 | 5 | 131
|
136 | 1005 Ciruela F, Gomez-Soler M, Guidolin D, Borroto-Escuela DO, Agnati LF, et al.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. 2011 MAY; 1808 (5): 1245-1255
| 0 | 0 | 1 | 131
|
137 | 156 Jorge RE, Starkstein SEJOURNAL OF HEAD TRAUMA REHABILITATION. 2005 NOV-DEC; 20 (6): 475-487
| 0 | 29 | 1 | 130
|
138 | 891 Miller DK, Bowirrat A, Manka M, Miller M, Stokes S, et al.POSTGRADUATE MEDICINE. 2010 NOV; 122 (6): 188-213
| 1 | 2 | 3 | 129
|
139 | 902 Casey BJ, Jones RMJOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. 2010 DEC; 49 (12): 1189-1201
| 0 | 0 | 3 | 128
|
140 | 99 Buonopane A, Petrakis ILSUBSTANCE USE & MISUSE. 2005; 40 (13-14): 2001-2020
| 0 | 12 | 1 | 127
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
141 | 503 Gullo MJ, Dawe SNEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2008 OCT; 32 (8): 1507-1518
| 3 | 16 | 4 | 127
|
142 | 653 Coppa-Hopman RD, Galle J, Pimkine DJOURNAL OF PSYCHOPHARMACOLOGY. 2009 AUG; 23 (6): 672-685
| 0 | 2 | 2 | 127
|
143 | 987 Blum K, Liu YJ, Shriner R, Gold MSCURRENT PHARMACEUTICAL DESIGN. 2011 APR; 17 (12): 1158-1167
| 0 | 0 | 7 | 127
|
144 | 731 Corominas M, Roncero C, Casas MLIFE SCIENCES. 2010 JAN 2; 86 (1-2): 1-9
| 0 | 3 | 10 | 126
|
145 | 859 Conway KP, Levy J, Vanyukoy M, Chandler R, Rutter J, et al.DRUG AND ALCOHOL DEPENDENCE. 2010 SEP 1; 111 (1-2): 4-12
| 0 | 2 | 7 | 126
|
146 | 944 Schwabe L, Dickinson A, Wolf OTEXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY. 2011 FEB; 19 (1): 53-63
| 0 | 0 | 8 | 126
|
147 | 151 Volkow ND, Li TKPHARMACOLOGY & THERAPEUTICS. 2005 OCT; 108 (1): 3-17
| 3 | 36 | 7 | 125
|
148 | 280 Corominas M, Roncero C, Bruguera E, Casas MREVISTA DE NEUROLOGIA. 2007 JAN 1; 44 (1): 23-31
| 1 | 9 | 5 | 125
|
149 | 862 Brewer JA, Bowen S, Smith JT, Marlatt GA, Potenza MNADDICTION. 2010 OCT; 105 (10): 1698-1706
| 1 | 4 | 8 | 125
|
150 | 225 Lapish CC, Seamans JK, Chandler LJALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 2006 SEP; 30 (9): 1451-1465
| 3 | 27 | 3 | 124
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
151 | 303 Baicy K, London EDADDICTION. 2007 APR; 102: 5-15
| 7 | 19 | 4 | 123
|
152 | 672 Alloy LB, Bender RE, Wagner CA, Whitehouse WG, Abramson LY, et al.JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY. 2009 SEP; 97 (3): 549-565
| 0 | 4 | 4 | 123
|
153 | 290 Moffett MC, Vicentic A, Kozel M, Plotsky P, Francis DD, et al.BIOCHEMICAL PHARMACOLOGY. 2007 FEB 1; 73 (3): 321-330
| 0 | 39 | 4 | 122
|
154 | 746 Mason BJ, Heyser CJCNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 MAR; 9 (1): 23-32
| 0 | 1 | 1 | 122
|
155 | 850 Fernandez-Serrano MJ, Perez-Garcia M, Rio-Valle JS, Verdejo-Garcia AJOURNAL OF PSYCHOPHARMACOLOGY. 2010 SEP; 24 (9): 1317-1332
| 4 | 4 | 20 | 122
|
156 | 638 Craig IW, Halton KEHUMAN GENETICS. 2009 JUL; 126 (1): 101-113
| 1 | 6 | 4 | 121
|
157 | 304 Aron JL, Paulus MPADDICTION. 2007 APR; 102: 33-43
| 14 | 25 | 7 | 120
|
158 | 482 Dalley JW, Mar AC, Economidou D, Robbins TWPHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR. 2008 AUG; 90 (2): 250-260
| 6 | 65 | 4 | 120
|
159 | 841 Taylor MA, Shorter E, Vaidya NA, Fink MACTA PSYCHIATRICA SCANDINAVICA. 2010 SEP; 122 (3): 173-183
| 0 | 4 | 0 | 120
|
160 | 916 Fontenelle LF, Oostermeijer S, Harrison BJ, Pantelis C, Yucel MDRUGS. 2011; 71 (7): 827-840
| 0 | 0 | 10 | 120
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
161 | 986 Amanzio M, Torta DME, Sacco K, Cauda F, D'Agata F, et al.BRAIN. 2011 APR; 134: 1061-1076
| 0 | 0 | 2 | 120
|
162 | 1047 Mackenzie RNEUROETHICS. 2011 JUL; 4 (2): 103-117
| 0 | 1 | 12 | 119
|
163 | 268 Everitt BJ, Hutcheson DM, Ersche KD, Pelloux Y, Dalley JW, et al.LINKING AFFECT TO ACTION: CRITICAL CONTRIBUTIONS OF THE ORBITOFRONTAL CORTEX. 2007; 1121: 576-597
| 21 | 40 | 17 | 118
|
164 | 527 Vocci FJEXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY. 2008 DEC; 16 (6): 484-497
| 4 | 12 | 17 | 118
|
165 | 243 Morgan CJA, Curran HVPSYCHOPHARMACOLOGY. 2006 NOV; 188 (4): 408-424
| 0 | 28 | 2 | 117
|
166 | 803 Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, et al.BRAIN. 2010 JUN; 133: 1779-1797
| 0 | 7 | 2 | 116
|
167 | 336 de Haes JIU, Maguire RP, Jager PL, Paans AMJ, den Boer JAHUMAN BRAIN MAPPING. 2007 JUL; 28 (7): 625-635
| 2 | 8 | 3 | 115
|
168 | 692 Brown RM, Lawrence AJNEUROCHEMICAL RESEARCH. 2009 OCT; 34 (10): 1876-1887
| 0 | 1 | 6 | 115
|
169 | 832 Oberlin BG, Bristow RE, Heighton ME, Grahame NJALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 2010 AUG; 34 (8): 1363-1375
| 0 | 0 | 2 | 115
|
170 | 139 Kamarajan C, Porjesz B, Jones KA, Choi K, Chorlian DB, et al.BIOLOGICAL PSYCHOLOGY. 2005 JUL; 69 (3): 353-373
| 11 | 40 | 1 | 114
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
171 | 321 Peoples LL, Kravitz AV, Lynch KG, Cavanaugh DJNEUROPSYCHOPHARMACOLOGY. 2007 MAY; 32 (5): 1141-1158
| 1 | 6 | 3 | 114
|
172 | 53 Clark L, Cools R, Robbins TWBRAIN AND COGNITION. 2004 JUN; 55 (1): 41-53
| 12 | 118 | 1 | 113
|
173 | 54 Volkow ND, Fowler JS, Wang GJ, Swanson JMMOLECULAR PSYCHIATRY. 2004 JUN; 9 (6): 557-569
| 49 | 217 | 2 | 113
|
174 | 575 Leeman RF, Grant JE, Potenza MNBEHAVIORAL SCIENCES & THE LAW. 2009 MAR-APR; 27 (2): 237-259
| 0 | 0 | 9 | 113
|
175 | 758 Ma LS, Wang BQ, Narayana S, Hazeltine E, Chen XY, et al.BRAIN RESEARCH. 2010 MAR 8; 1318: 64-76
| 0 | 2 | 1 | 113
|
176 | 143 Kalivas PW, Volkow NDAMERICAN JOURNAL OF PSYCHIATRY. 2005 AUG; 162 (8): 1403-1413
| 121 | 588 | 7 | 112
|
177 | 783 Grigorenko EL, DeYoung CG, Eastman M, Getchell M, Haeffel GJ, et al.AGGRESSIVE BEHAVIOR. 2010 MAY-JUN; 36 (3): 158-176
| 0 | 0 | 2 | 112
|
178 | 934 Huang YH, Schluter OM, Dong YBEHAVIOURAL BRAIN RESEARCH. 2011 JAN 1; 216 (1): 9-18
| 0 | 0 | 9 | 111
|
179 | 212 Laviolette SR, Grace AACELLULAR AND MOLECULAR LIFE SCIENCES. 2006 JUL; 63 (14): 1597-1613
| 3 | 55 | 4 | 110
|
180 | 430 Clark DB, Thatcher DL, Tapert SFALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 2008 MAR; 32 (3): 375-385
| 0 | 23 | 2 | 110
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
181 | 802 Ersche KD, Bullmore ET, Craig KJ, Shabbir SS, Abbott S, et al.ARCHIVES OF GENERAL PSYCHIATRY. 2010 JUN; 67 (6): 632-644
| 2 | 3 | 19 | 110
|
182 | 953 Economidou D, Dalley JW, Everitt BJBIOLOGICAL PSYCHIATRY. 2011 FEB 1; 69 (3): 266-274
| 1 | 1 | 16 | 110
|
183 | 81 Kenna GA, McGeary JE, Swift RMAMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2004 NOV 15; 61 (22): 2380-2388
| 2 | 19 | 1 | 109
|
184 | 406 Ryding E, Lindstrom M, Traskman-Bendz LSEROTONIN-DOPAMINE INTERACTION: EXPERIMENTAL EVIDENCE AND THERAPEUTIC RELEVANCE. 2008; 172: 307-315
| 0 | 15 | 1 | 109
|
185 | 966 Payer DE, Lieberman MD, London EDARCHIVES OF GENERAL PSYCHIATRY. 2011 MAR; 68 (3): 271-282
| 0 | 0 | 9 | 109
|
186 | 356 Garavan H, Hester RNEUROPSYCHOLOGY REVIEW. 2007 SEP; 17 (3): 337-345
| 19 | 33 | 13 | 108
|
187 | 816 Lotrich FE, Ferrell RE, Rabinovitz M, Pollock BGCLINICAL NEUROPHARMACOLOGY. 2010 JUL; 33 (4): 191-197
| 0 | 2 | 1 | 108
|
188 | 976 Heatherton TF, Wagner DDTRENDS IN COGNITIVE SCIENCES. 2011 MAR; 15 (3): 132-139
| 0 | 1 | 9 | 108
|
189 | 458 Hearing MC, Miller SW, See RE, McGinty JFPSYCHOPHARMACOLOGY. 2008 MAY; 198 (1): 77-91
| 4 | 12 | 4 | 107
|
190 | 460 Harris GJ, Jaffin SK, Hodge SM, Kennedy D, Caviness VS, et al.ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 2008 JUN; 32 (6): 1001-1013
| 3 | 22 | 3 | 107
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
191 | 967 Alia-Klein N, Parvaz MA, Woicik PA, Konova AB, Maloney T, et al.ARCHIVES OF GENERAL PSYCHIATRY. 2011 MAR; 68 (3): 283-294
| 0 | 0 | 13 | 107
|
192 | 59 de Mendelssohn A, Kasper S, Tauscher JNERVENARZT. 2004 JUL; 75 (7): 651-+
| 0 | 4 | 1 | 106
|
193 | 201 Ersche KD, Clark L, London M, Robbins TW, Sahakian BJNEUROPSYCHOPHARMACOLOGY. 2006 MAY; 31 (5): 1036-1047
| 20 | 52 | 5 | 106
|
194 | 446 Karila L, Weinstein A, Benyamina A, Coscas S, Leroy C, et al.PRESSE MEDICALE. 2008 APR; 37 (4): 689-698
| 1 | 6 | 5 | 106
|
195 | 666 Li CSR, Zhang S, Duann JR, Yan PS, Sinha R, et al.BRAIN IMAGING AND BEHAVIOR. 2009 SEP; 3 (3): 262-276
| 0 | 1 | 5 | 106
|
196 | 981 Grosshans M, Loeber S, Kiefer FADDICTION BIOLOGY. 2011 APR; 16 (2): 189-198
| 0 | 0 | 4 | 106
|
197 | 288 Hu XTMOLECULAR NEUROBIOLOGY. 2007 FEB; 35 (1): 95-112
| 2 | 7 | 5 | 105
|
198 | 804 Naqvi NH, Bechara ABRAIN STRUCTURE & FUNCTION. 2010 JUN; 214 (5-6): 435-450
| 0 | 3 | 8 | 105
|
199 | 820 Kamarajan C, Rangaswamy M, Tang YQ, Chorlian DB, Pandey AK, et al.JOURNAL OF PSYCHIATRIC RESEARCH. 2010 JUL; 44 (9): 576-590
| 0 | 0 | 10 | 105
|
200 | 956 Langas AM, Malt UF, Opjordsmoen SBMC PSYCHIATRY. 2011 FEB 12; 11: Art. No. 25
| 0 | 0 | 3 | 105
|